Chemomab Therapeutics Announces Closing of $10 Million

Chemomab Therapeutics Announces Closing Of $10 Million

1 week from now

Jul 30, 2024  · Chemomab Therapeutics Announces Closing of $10 Million Private Placement. July 30, 2024 09:00 ET | Source: Chemomab Therapeutics. Follow. — HBM Healthcare Investments, OrbiMed and Sphera Biotech ...

globenewswire.com

Chemomab Therapeutics Announces Closing Of $10 Million Private …

1 week from now

Jul 30, 2024  · Pursuant to the terms of the transaction, the Company sold a total of 8,097,167 ADSs and pre-funded warrants in lieu of ADSs. The purchase price per ADS was $1.235. The …

yahoo.com

Chemomab Therapeutics Announces Closing Of $10 Million Private ...

1 week from now

Jul 30, 2024  · About Chemomab Therapeutics Ltd. Chemomab is a clinical stage biotechnology company developing innovative therapeutics for fibro-inflammatory diseases with high unmet …

morningstar.com

Chemomab Therapeutics Announces Third Quarter 2024 …

1 week from now

3 days ago  · Cash Position and Liquidity: Cash and short-term bank deposits were $19.5 million as of September 30, 2024, as compared to $12.8 million as of June 30, 2024 and $19.9 million …

chemomab.com

Chemomab Therapeutics Announces Third Quarter 2024 Financial …

1 week from now

2 days ago  · During the third quarter of 2024 Chemomab completed a private placement that resulted in gross proceeds to the company of approximately $10 million. Chemomab believes …

businessinsider.com

Chemomab Therapeutics Announces $10 Million Private Placement

1 week from now

Jul 25, 2024  · Chemomab Therapeutics Announces $10 Million Private Placement. Chemomab Therapeutics. Chemomab Therapeutics . Thu, Jul 25, ... The PIPE is expected to close on or …

yahoo.com

Chemomab Therapeutics Announces $10 Million Private

1 week from now

Jul 25, 2024  · Chemomab announced a $10 million PIPE that enables the company to extend its cash runway until early 2026, well past 2 upcoming milestones in early 2025....

globenewswire.com

Chemomab Therapeutics Secures $10 Million Private Placement

1 week from now

July 30, 2024. Chemomab Therapeutics Announces Closing of $10 Million Private Placement. Recently, Chemomab Therapeutics Ltd announced the successful closing of a $10 million …

csimarket.com

Chemomab Therapeutics Announces Closing Of $10 Million Private …

1 week from now

Jul 30, 2024  · Chemomab Therapeutics Announces Closing of $10 Million Private Placement. TEL AVIV, Israel — July 30, 2024 — Chemomab Therapeutics Ltd. (Nasdaq: CMMB) …

chemomab.com

Chemomab Therapeutics Announces Second Quarter 2024 …

1 week from now

Aug 21, 2024  · Cash Position: Cash, cash equivalents and short-term bank deposits were $12.8 million as of June 30, 2024, compared to $19.9 million as of December 31, 2023. On July 30, …

chemomab.com

Chemomab Therapeutics Announces $10 Million Private Placement

1 week from now

Jul 25, 2024  · It indicates a way to close an interaction, or dismiss a notification. ... Chemomab Therapeutics Announces $10 Million Private Placement. PRESS RELEASE GlobeNewswire . …

businessinsider.com

Chemomab Therapeutics Sees Cash Runway Through Beginning Of …

1 week from now

3 days ago  · Cash and short-term bank deposits were $19.5 million as of September 30, 2024, as compared to $12.8 million as of June 30, 2024 and $19.9 million as of December 31, 2023. …

businessinsider.com

Chemomab Therapeutics Announces $10 Million Private Placement

1 week from now

Jul 25, 2024  · Chemomab Therapeutics Announces $10 Million Private Placement Provided by GlobeNewswire. Jul 25, 2024 11:38am ... 2024, subject to satisfaction of customary closing …

morningstar.com

Inhibikase Therapeutics Reports Third Quarter Financial ... - BioSpace

1 week from now

1 day ago  · Net Loss: Net loss for the quarter ended September 30, 2024, was $5.8 million, or $0.65 per share, compared to a net loss of $4.6 million, or $0.75 per share in the quarter …

biospace.com

Chemomab Therapeutics Announces Third Quarter 2024

1 week from now

2 days ago  · During the third quarter of 2024 Chemomab completed a private placement that resulted in gross proceeds to the company of approximately $10 million. Chemomab believes …

globenewswire.com

Chemomab Therapeutics Announces Closing Of $10 Million Private ...

1 week from now

Jul 30, 2024  · Chemomab Therapeutics Announces Closing of $10 Million Private Placement. — HBM Healthcare Investments, OrbiMed and Sphera Biotech Master Fund LP Participated in …

biospace.com

Chemomab Therapeutics Announces $10 Million Private Placement

1 week from now

Jul 25, 2024  · Chemomab Therapeutics Announces $10 Million Private Placement. Published. Jul 25, 2024 7:38am EDT. TEL AVIV, Israel, July 25, 2024 (GLOBE NEWSWIRE) -- Chemomab …

nasdaq.com

Panbela Therapeutics Announces Q3 2024 Financial Results

1 week from now

2 days ago  · In its Q3 2024 financial report, Panbela Therapeutics highlighted a significant strategic investment of up to $12 million from Nant Capital, which is expected to bolster its …

businessinsider.com

Chemomab Therapeutics Announces Third Quarter 2024 Financial …

1 week from now

3 days ago  · Cash Position and Liquidity: Cash and short-term bank deposits were $19.5 million as of September 30, 2024, as compared to $12.8 million as of June 30, 2024 and $19.9 million …

chemomab.com

Chemomab Therapeutics Announces Closing Of $10 Million …

1 week from now

Jul 30, 2024  · “Company”), a clinical stage biotechnology company developing innovative therapeutics for fibro-inflammatory diseases with high unmet need, today announced that it …

chemomab.com

Chemomab Therapeutics Announces $10 Million Private Placement

1 week from now

TEL AVIV, Israel — July 25, 2024 — Chemomab Therapeutics Ltd. (Nasdaq: CMMB) (“Chemomab” or the “Company”), a clinical stage biotechnology company developing …

chemomab.com